Brief: Collplant Announces Development Program Of Antiviral Agent For Potential Treatment Of Covid-19 Patients

Collplant Biotechnologies

10/11/2020 12:50

Nov 10 (Reuters) - Collplant Biotechnologies Ltd  CPTGy.F :
    * COLLPLANT - ANNOUNCED DEVELOPMENT PROGRAM OF ANTIVIRAL
AGENT FOR
POTENTIAL TREATMENT OF COVID-19 PATIENTS
    * COLLPLANT - IN-VITRO EARLY RESULTS OF CO'S FORMULATIONS
SHOWED
SIGNIFICANT INHIBITION OF AVIAN CORONAVIRUS INFECTIVITY

Source text for Eikon:  ID:nPnc9JRVPa 
Further company coverage:  CPTGy.F 

 ((Reuters.Briefs@thomsonreuters.com;))